Among the genetic factors, the influence of Apolipoprotein E (APOE) polymorphisms on DN development has been extensively studied in both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) populations [12–14]. This evidence concerns the gene APOE and type 2 diabetes mellitus.